Cited by 445Probiotics and Fermented FoodsGut microbiota and healthGastrointestinal motility and disorders

Probiotic supplements might not be universally-effective and safe: A review

Open access
Kothari, Damini, Patel, Seema, Kim, Soo-Ki·2019·Biomedicine & Pharmacotherapy

Abstract

Last few decades have witnessed the unprecedented growth in the application of probiotics for promoting the general gut health as well as their inception as biotherapeutics to alleviate certain clinical disorders related to dysbiosis. While numerous studies have substantiated the health-restoring potentials for a restricted group of microbial species, the marketed extrapolation of a similar probiotic label to a large number of partially characterized microbial formulations seems biased. In particular, the individuals under neonatal stages and/or those with some clinical conditions including malignancies, leaky gut, diabetes mellitus, and post-organ transplant convalescence likely fail to reap the benefits of probiotics. Further exacerbating the conditions, some probiotic strains might take advantage of the weak immunity in these vulnerable groups and turn into opportunistic pathogens engendering life-threatening pneumonia, endocarditis, and sepsis. Moreover, the unregulated and rampant use of probiotics potentially carry the risk of plasmid-mediated antibiotic resistance transfer to the gut infectious pathogens. In this review, we discuss the safety perspectives of probiotics and their therapeutic interventions in certain at-risk population groups. The embodied arguments and hypotheses certainly will shed light on the fact why probiotic usage should be treated with caution.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.biopha.2018.12.104

Cites

138 of 138 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Evidence from short-term observations suggests that certain probiotic strains might behave as opportunistic pathogens in populations who are immunocompromised, stressed, aged, or newly born.

    “Evidence from short-term observations suggest that certain probiotic strains might behave as opportunistic pathogens in populations who are immunocompromised, stressed, aged, or newly born.105”

    From Emerging issues in probiotic safety: 2023 perspectives (2023) · cites this paper as [105]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. M. Martín Muñoz, T. Caballero, M. Caminoa, M. Belver, E. Rojas, S. Quirce, Allergy to a probiotic compound, Allergy Eur. J. Allergy Clin. Immunol. 64 (2009) 200 http://www.embase.com/search/results?subaction=viewrecord&from=export& id=L70020425%5Cnhttps://doi.org/10.1111/j.1398-9995.2009.02076.x. · DOI

Cited by

Sorted by citations

Authors
Kothari, D., Patel, S., & Kim, S.-K.
Affiliations
  • Konkuk University (KR)
  • San Diego State University (US)
Corresponding author
  • Patel, Seema
  • Kim, Soo-Ki
Venue
Biomedicine & Pharmacotherapy
Publisher
Elsevier BV
Published
2019-03
Volume
111
Pages
537-547
ISSN
0753-3322 (ISSN-L)
OpenAlex
W2907009484
Cited by
445
References
138
Citations by year
2026: 48 · 2025: 75 · 2024: 73 · 2023: 63 · 2022: 62 · 2021: 63 · 2020: 43 · 2019: 18
FWCI
3.13
Type
journal article
Language
en
Open access
Locations
  • Biomedicine & Pharmacotherapy (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries
  • Ministry of Agriculture, Food and Rural Affairs (118051-03)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Keywords
probiotics, probiotic safety, probiotic efficacy, dysbiosis, gut health, neonates, immunocompromised patients, opportunistic pathogens, antibiotic resistance transfer, plasmid-mediated antibiotic resistance, leaky gut, diabetes mellitus, probiotic regulation
MeSH terms
Gastrointestinal Microbiome, Systematic Reviews as Topic, Animals, Endocarditis, Bacterial, Humans, Randomized Controlled Trials as Topic, Sepsis, Dietary Supplements, Probiotics, Dysbiosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review